EUCTR2004-002501-72-DE进行中（未招募）不适用
Studie zur neoadjuvanten Therapie bei Hochrisikopatienten mit Weichteilsarkom (STS) im Erwachsenenalter - Neoadjuvante Studie bei Weichteilsarkomen
未提供0 个研究点开始时间: 2004年10月20日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •siehe Seite 6 des Protokolls
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •siehe Seite 6 + 7 des Protokolls
研究者
相似试验
已完成
2 期
Prospective feasible study to evaluate neoadjuvant chemoradiotherapy for locally advanced rectal Cancer (Neoadjuvant-synchronus TS1+RT)rectal cancerJPRN-UMIN000003396Oita University faculty of medicine, Department of Surgery I35
进行中（未招募）
1 期
eoadjuvant Lu-PSMA radioligand therapy and Ipilimumab in men with very high-risk prostate cancer (NEPI)Patients with very high-risk prostate cancer (as defined by a total Gleason-Score =4+4 [ISUP-GG 4+5] and clinical stage cT3 (digital rectal examinations or imaging based) plus clinical nodal status cN+ or Serum-PSA level > 20 ng/ml who are candidates for radical prostatectomy with pelvic lymph node dissection.CTIS2024-514386-19-00niversitaetsklinikum Essen AöR58
招募中
2 期
eoadjuvant DOS treatment for advanced esophageal cancerEsophageal cancerJPRN-jRCTs041210023Kodera Yasuhiro45
招募中
不适用
Clinical efficacy study of neoadjuvant therapy with intensity-modulated radiotherapy combined with S-1 for resectable pancreatic cancerpancreatic cancerJPRN-UMIN000046456Kyoto Katsura Hospital40
进行中（未招募）
不适用
Phase II trial assessing neoadjuvant therapy with FEC 100 followed by Taxotere® (docetaxel) plus Vectibix® (panitumumab) in patients with operable, HR and Her-2 negative breast cancer. TVA study. - TVA studyRH- and Her2- operable breast cancer, in neoadjuvant situationMedDRA version: 9.1Level: LLTClassification code 10022882Term: Invasive ductal breast cancerEUCTR2009-012853-39-FRCentre Jean Perrin